NVision
PrivateLast Round
Series B
May 13, 2026
Est. Valuation
$250M
Total Funding Raised
$194.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NVision is a quantum technology company that develops quantum-based systems for healthcare, including quantum-enhanced MRI for metabolic imaging and quantum computing for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Quantum Computing, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NVision Comparables
Compare NVision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantView GmbH | 76% | |
| GE HealthCare Technologies Inc. | 75% | |
| Bruker | 74% |
NVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2026 | ||||
| Series B | May 13, 2026 | ||||
| Grant | Mar 16, 2026 | ||||
| Series B | May 13, 2024 | ||||
| Series A | Jun 22, 2023 |
NVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| European Commission | Seed |
| Entrée Capital | Series B, Series A |
| Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH | Series A |
| European Investment Bank Group | Series B |
| Matterwave Ventures | Series B |
| CDP Venture Capital SGR | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$55M round led by Abbott Laboratories.
- May 13, 2026
$55M round led by Abbott Laboratories
Recent news
Latest coverage and updates
- partners_withSep 1, 2026
Nvision Quantum partnered with Memorial Sloan Kettering Cancer Center on Sep 1st '26.
NVision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NVision's valuation, stock price, and market status.
Is NVision a public or private company?
NVision is a private company.
What is the current stock price of NVision?
NVision is a private company, so its shares have no public market price. Caplight tracks NVision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NVision worth (valuation)?
NVision's valuation is estimated at $250.0M based on funding round data.
Can I buy NVision stock?
NVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NVision's last funding round?
NVision's most recent funding round was Series B on May 13, 2026.
Who are the main investors in NVision?
Key investors in NVision include Playground Global.
Will NVision IPO soon?
No public IPO plans have been announced for NVision.
How can I track NVision secondary market activity?
Caplight tracks bids, offers, and trades in NVision's shares on secondary markets.